cancer vaccine
This virtual two-day symposium will gather researchers to present the latest breakthroughs in cancer immunology.
| 4 min read
Cancer diagnostic technologies, advances on brain map models, pharmaceutical deals, and more led the news this week.
| 4 min read
Rare disease approvals, multi-billion-dollar deals, and more led this week’s headlines.
| 3 min read
Final results from the AMPLIFY-201 phase 1 trial highlight durable T cell responses and prolonged survival in patients with colorectal and pancreatic cancer.
| 5 min read
IO Biotech’s two-pronged cancer vaccine targets tumors and the suppressive immune cells around them, demonstrating promising results in metastatic melanoma.
Page 1 of 1 - 5 Total Items
